Overview

BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333)

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the blood pressure efficacy between losartan and valsartan at equivalent dosage during a 3 months treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Hydrochlorothiazide
Losartan
Valsartan